Suppr超能文献

印度北部急性脑炎患儿经验性阿昔洛韦治疗模式的观察性研究

An Observational Study on Pattern of Empirical Acyclovir Therapy in Children With Acute Encephalitis From Northern India.

作者信息

Adarsha Naik, Samprathi Madhusudan, Sankhyan Naveen, Singh Mini P, Bansal Arun, Jayashree Muralidharan, Angurana Suresh Kumar, Nallasamy Karthi

机构信息

Department of Pediatrics, Kasturba Medical College, Manipal, Karnataka, India.

Department of Pediatrics, All India Institute of Medical Sciences Bibinagar, Hyderabad Metropolitan Region, Telangana, India.

出版信息

Pediatr Crit Care Med. 2023 Jul 1;24(7):e322-e331. doi: 10.1097/PCC.0000000000003237. Epub 2023 Apr 25.

Abstract

OBJECTIVES

To identify the prevalence of herpes simplex encephalitis (HSE), factors influencing the duration of empirical acyclovir and frequency of acute kidney injury (AKI) in children with acute encephalitis syndrome (AES).

DESIGN

Prospective observational study.

SETTING

Pediatric Emergency Department and PICU of a tertiary hospital in Northern India.

PATIENTS

All consecutive, eligible children between 1 month and 12 years old presenting with AES, defined as altered consciousness for greater than 24 hours (including lethargy, irritability, or a change in personality) and two or more of the following signs: 1) fever (temperature ≥ 38°C) during the current illness, 2) seizures or focal neurological signs, 3) cerebrospinal fluid (CSF) pleocytosis, 4) electroencephalogram, and/or 5) neuroimaging suggesting encephalitis, who received at least one dose of acyclovir.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Of the 101 children screened, 83 were enrolled. The median (interquartile range [IQR]) age was 3 years (1-6 yr). Thirty-one children (37.3%) were diagnosed with AES, of which four were labeled as probable HSE (three based on MRI brain, one based on serology). Scrub typhus, dengue, Japanese encephalitis, and mumps were the other infective causes. The median (IQR) duration of acyclovir therapy was 72 hours (24-264 hr); 21 children (25.3%) received acyclovir for less than 24 hours and 11 (13.3%) for greater than or equal to 14 days. New-onset AKI was seen in 18 children (21.7%) but was mostly transient. Death ( n = 8, 9.6%) and discontinuation of care due to futility or other reasons ( n = 15, 18%) were noted in 23 children (28%). Factors associated with duration of acyclovir greater than 7 days, on univariable analysis, were lower modified Glasgow Coma Score at admission, requirement of invasive ventilation, invasive intracranial pressure monitoring, and CSF pleocytosis (5-500 cells). On multivariable analysis, only CSF pleocytosis of 5-500 cells was associated with duration of acyclovir greater than 7 days.

CONCLUSIONS

Given the low prevalence of HSE, and the risk of AKI, this study sensitizes the need to review our practice on initiation and stopping of empirical acyclovir in children with acute encephalitis.

摘要

目的

确定急性脑炎综合征(AES)患儿中单纯疱疹性脑炎(HSE)的患病率、影响经验性使用阿昔洛韦疗程的因素以及急性肾损伤(AKI)的发生频率。

设计

前瞻性观察性研究。

地点

印度北部一家三级医院的儿科急诊科和儿科重症监护病房。

患者

所有连续就诊的1个月至12岁符合条件的AES患儿,AES定义为意识改变超过24小时(包括嗜睡、易激惹或性格改变),并伴有以下两种或更多体征:1)本次患病期间发热(体温≥38°C),2)癫痫发作或局灶性神经体征,3)脑脊液(CSF)细胞增多,4)脑电图,和/或5)提示脑炎的神经影像学检查,且接受了至少一剂阿昔洛韦治疗。

干预措施

无。

测量指标及主要结果

在筛查的101名儿童中,83名被纳入研究。中位(四分位间距[IQR])年龄为3岁(1 - 6岁)。31名儿童(37.3%)被诊断为AES,其中4名被标记为可能的HSE(3名基于头颅MRI,1名基于血清学)。恙虫病、登革热、日本脑炎和腮腺炎是其他感染原因。阿昔洛韦治疗的中位(IQR)疗程为72小时(24 - 264小时);21名儿童(25.3%)接受阿昔洛韦治疗少于24小时,11名(13.3%)接受治疗大于或等于14天。18名儿童(21.7%)出现新发AKI,但大多为短暂性。23名儿童(28%)出现死亡(n = 8,9.6%)以及因治疗无效或其他原因停止治疗(n = 15,18%)。单因素分析显示,与阿昔洛韦疗程大于7天相关的因素包括入院时改良格拉斯哥昏迷评分较低、需要有创通气、有创颅内压监测以及CSF细胞增多(5 - 500个细胞)。多因素分析显示,只有CSF细胞增多5 - 500个细胞与阿昔洛韦疗程大于7天相关。

结论

鉴于HSE患病率较低以及存在AKI风险,本研究提示有必要重新审视我们对急性脑炎患儿经验性使用阿昔洛韦起始和停药的做法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验